The Imagion Biosystems Annual Report for the year ended 31 December 2018 is available here. Download the 2018 Annual Report.
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal